Selective, physiological transport of insulin across the blood-brain barrier. Novel demonstration by species-specific radioimmunoassays

Peptides

Volumn 18, Issue 8, 1997, Pages 1257-1262

  Banks, William A ^a   Jaspan, Jonathan B ^a   Kastin, Abba J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain; Cerebrospinal fluid; Glucose; Insulin; Transport

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CONTROLLED STUDY; GLUCOSE TRANSPORT; HORMONE TRANSPORT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; TRANSPORT KINETICS;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INSULIN; MALE; MICE; MICE, INBRED ICR; RADIOIMMUNOASSAY; SPECIES SPECIFICITY;

ANIMALIA; MURINAE;

EID: 0031456345     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00198-8     Document Type: Article

References (32)

1. Ajaya B., Haranath P. S. R. K. Effects of insulin administered into cerebrospinal fluid spaces on blood glucose in unanaesthestized and anaesthestized dogs. Indian J. Med. Res. 75:1982;607-615.
2. Banks W. A., Kastin A. J. Peptides and the blood-brain barrier lipophilicity as a predictor of permeability . Brain Res. Bull. 15:1985;287-292.
3. Banks W. A., Kastin A. J. The aluminum-induced increase in blood-brain barrier permeability to delta-sleep-inducing peptide occurs throughout the brain and is independent of phosphorus and acetylcholinesterase levels. Psychopharmacology (Berlin). 86:1985;84-89.
4. Banks W. A., Kastin A. J. Physiological consequences of the passage of peptides across the blood-brain barrier. Rev. Neurosci. 4:1993;365-372.
5. Banks W. A., Kastin A. J., Broadwell R. D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation. 2:1995;241-248.
6. Baskin D. G., Brewitt B., Davidson D. A., Corp E., Paquette T., Figlewicz D. P., Lewellen T. K., Graham M. K., Woods S. C., Dorsa D. M. Quanitative autoradiographic evidence for insulin receptors in the choroid plexus of the rat brain. Diabetes. 35:1986;246-249.
7. Baskin D. G., Wilcox B. J., Figlewicz D. P., Dorsa D. M. Insulin and insulin-like growth factors in the CNS. Trends Neurosci. 11:1988;107-111.
8. Baura G. D., Foster D. M., Porte D. Jr, Kahn S. E., Bergman R. N., Cobelli C., Schwartz M. W. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo a mechanism for regulated insulin delivery to the brain . J. Clin. Invest. 92:1993;1824-1830.
9. Begley D. J. Strategies for delivery of peptide drugs to the central nervous system exploiting molecular structure . J. Control. Release. 29:1994;293-306.
10. Broadwell R. D., Sofroniew M. V. Serum proteins by-pass the blood-brain barrier for extracellular entry to the central nervous system. Exp. Neurol. 120:1993;245-263.
11. Chikhale E. G., Ng K. Y., Burton P. S., Borchardt R. T. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm. Res. 11:1994;412-419.
12. Davson, H.; Segal, M. B. The proteins and other macromolecules of the CSF. In: Physiology of the CSF and the blood-brain barrier. Boca Raton: CRC Press; 1996:573-606.
13. Faggioni R., Benigni F., Ghezzi P. Proinflammatory cytokines as pathogenetic mediators in the central nervous system brain-periphery connections . Neuroimmunomodulation. 2:1995;2-15.
14. Figlewicz D. P., Sipols A. J., Seeley R. J., Chaves M., Woods S. C., Porte D. Jr. Intraventricular insulin enhances the meal-suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon. Behav. Neurosci. 109:1995;567-569.
15. Florant G. L., Singer L., Scheurink A. J. W., Park C. R., Richardson R. D., Woods S. C. Intraventricular insulin reduces food intake and body weight of marmots during the summer feeding period. Physiol. Behav. 49:1991;335-338.
16. Foster L. A., Ames N. K., Emery R. S. Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I. Physiol. Behav. 50:1991;745-749.
17. Frankish H. M., Dryden S., Hopkins D., Wang Q., Williams G. Neuropeptide Y, the hypothalamus, and diabetes insights into the central control of metabolism . Peptides. 16:1995;757-771.
18. Henneberg N., Hoyer S. Short-term or long-term intracerebroventricular (i. c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat. Neurosci. Lett. 175:1994;153-156.
19. Hotamisligil G. S., Speigelman B. M. Tumor necrosis factor alpha a key component of the obesity-diabetes link . Diabetes. 43:1994;1271-1278.
20. Jeanrenaud B. Central nervous system and peripheral abnormalities clues to the understanding of obesity and NIDDM . Diabetologia. 37:(Suppl 2):1994;S169-S178.
21. Keller B. T., Borchardt R. T. Cultured bovine brain capillary endothelial cells (BBCEC) - a blood-brain barrier model for studying the binding and internalization of insulin and insulin-like growth factor 1. Fed. Proc. 46:1987;416.
22. Kluger M. J., Kozak W., Leon L. R., Soszynski D., Conn C. A. Cytokines and fever. Neuroimmunomodulation. 2:1995;216-223.
23. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. 27:1994;157-162.
24. Miller D. W., Borchardt R. T. Distribution of insulin binding sites on cultured bovine brain microvessel endothelial cells and their possible role in the transport of insulin across the blood-brain barrier. J. Cell Biol. 115:1991;261a.
25. Muntzel M. S., Morgan D. A., Mark A. L., Johnson A. K. Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. Am. J. Physiol. 267:1994;R1350-R1355.
26. Plata-Salaman C. R. Insulin in the cerebrospinal fluid. Neurosci. Biobehav. Rev. 15:1991;243-258.
27. Schwartz M. W., Bergman R. N., Kahn S. E., Taborsky G. L. Jr, Fisher L. D., Sipols A. J., Woods S. C., Steil G. M., Porte D. Jr. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. J. Clin. Invest. 88:1991;1272-1281.
28. Schwartz M. W., Figlewicz D. P., Baskin D. G., Woods S. C., Porte D. Jr. Insulin in the brain a hormonal regulator of energy balance . Endocrine Rev. 13:1992;387-414.
29. Schwartz M. W., Figlewicz D. P., Baskin D. G., Woods S. C., Porte D. Jr. Insulin and the central regulation of energy balance update 1994 . Endocrine Rev. 2:1994;109-113.
30. Schwartz M. W., Sipols A. J., Marks J. L., Sanacora G., White J. D., Scheurink A., Kahn S. E., Baskin D. G., Woods S. C., Figlewicz D. P., Porte D. Jr. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 130:1992;3608-3615.
31. Szczepanska-Sadowska E., Gray D., Simon-Oppermann C. Vasopressin in blood and third ventricle CSF during dehydration, thirst, and hemorrhage. Am. J. Physiol. 245:1983;R549-R555.
32. Zlokovic, B. V.; Begley, D. J.; Segal, M. B.; Davson, H.; Rakic, L.; Lipovac, M. N.; Mitrovic, D. M.; Jankov, R. M. Neuropeptide transport mechanisms in the central nervous system. In: Rakic L.; Begley D. J.; Davson H.; Zlokovic B. V., Eds. Peptide and amino acid transport mechanisms in the central nervous system. New York: Stockton Press; 1988:3-19.